These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16056093)

  • 1. Immunosuppression in pediatric liver and intestinal transplantation: a closer look at the arsenal.
    Al-Hussaini A; Tredger JM; Dhawan A
    J Pediatr Gastroenterol Nutr; 2005 Aug; 41(2):152-65. PubMed ID: 16056093
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.
    Otto C; Gasser M; Gassel HJ; Steger U; Timmermann W; Meyer D; Ulrichs K; Thiede A
    Transplant Proc; 1998 Aug; 30(5):2161-2. PubMed ID: 9723426
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
    Charpentier B
    Transplant Proc; 2001; 33(7-8):3334-6. PubMed ID: 11750425
    [No Abstract]   [Full Text] [Related]  

  • 4. Intestinal transplantation in children under FK 506 immunosuppression.
    Tzakis AG; Todo S; Reyes J; Nour B; Abu-Elmagd K; Selby R; Casavilla A; Kocoshis S; Demetris AJ; Yunis E
    J Pediatr Surg; 1993 Aug; 28(8):1040-3. PubMed ID: 7693907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
    Rafecas A; Lladó L; Albiol MT; Ramos E; Torras J; Fabregat J; Lama C; Busquets J; Ibáñez L; Figueras J; Jaurrieta E
    Transplant Proc; 2002 Feb; 34(1):107. PubMed ID: 11959209
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing perspectives on the role of corticosteroids after liver transplantation.
    Lucey MR
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S58-63. PubMed ID: 10431018
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved results in small bowel transplantation using sirolimus.
    Florman S; Gondolesi G; Schiano T; Tschernia A; LeLeiko N; Kaufman SS; Fishbein T
    Transplant Proc; 2002 May; 34(3):936. PubMed ID: 12034247
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience.
    Taylor RM; Cheeseman P; Rela M; Heaton N; Mieli-Vergani G; Dhawan A
    Transplant Proc; 2002 Aug; 34(5):1974-5. PubMed ID: 12176652
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 10. Current trends in immunosuppression.
    González Posada JM
    Nefrologia; 2006; 26 Suppl 2():3-8. PubMed ID: 17937629
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts and perspectives of immunosuppression in organ transplantation.
    Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
    Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression in liver transplantation.
    Post DJ; Douglas DD; Mulligan DC
    Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete withdrawal of immunosuppression in living donor liver transplantation.
    Oike F; Yokoi A; Nishimura E; Ogura Y; Fujimoto Y; Kasahara M; Kaihara S; Kiuchi T; Egawa H; Uemoto S; Tanaka K
    Transplant Proc; 2002 Aug; 34(5):1521. PubMed ID: 12176465
    [No Abstract]   [Full Text] [Related]  

  • 15. Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.
    Velio P; Tarantino C; Bertoglio C; Guffanti E; Bardella MT; Biffi R; Andreoni B; Rossi G; Gatti S; Piazzini A; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2529-30. PubMed ID: 8907936
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
    Hirose R; Roberts JP; Quan D; Osorio RW; Freise C; Ascher NL; Stock PG
    Transplantation; 2000 Jan; 69(2):307-11. PubMed ID: 10670644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.
    Vianna R
    Minerva Pediatr; 2009 Jun; 61(3):293-303. PubMed ID: 19461573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
    Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
    Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.